Avertd Intellipac Reagent Module
Payments companies reported to CMS as associated with Avertd Intellipac Reagent Module. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Avertd Intellipac Reagent Module, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Avertd Intellipac Reagent Module
These are the largest totals companies reported as associated with Avertd Intellipac Reagent Module. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Thomas Keller | Hanover, PA | Internal Medicine | $58.44 |
| Joanne Chan | Hanover, PA | Internal Medicine | $58.44 |
| Edwin Daniels | Waymart, PA | Physician Assistant | $55.71 |
| Kristen Daniels | Waymart, PA | Surgical | $55.71 |
| Jeffrey Mogerman | Waymart, PA | Orthopaedic Surgery | $55.71 |
| Priya Swamy | Broomall, PA | Physical Medicine & Rehabilitation | $44.60 |
| John Guzek | Scranton, PA | Internal Medicine | $44.07 |
| Russell Gombosi | Williamsport, PA | Internal Medicine | $21.92 |
| Dean Trevlyn | Broomall, PA | Orthopaedic Surgery | $20.01 |
| Sara Low | Broomall, PA | Hand Surgery | $20.01 |
Prescribed Avertd Intellipac Reagent Module?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.